The blind spot of p53

Anton Berns
Additional contact information
Anton Berns: Anton Berns is at the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. a.berns@nki.nl

Nature, 2010, vol. 468, issue 7323, 519-520

Abstract: It is hoped that reactivating the tumour-suppressor protein p53 will help to combat cancer. However, fresh evidence suggests it is unlikely that all cells in a tumour will respond to such treatment. See Letters p.567 & p.572

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/468519a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:468:y:2010:i:7323:d:10.1038_468519a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/468519a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().